Adenovirus type 4 and type 7
Ended Awarded
- Contract number
- SPE2DP26F7456
- Awardee
-
Teva Pharmaceuticals Usa, Inc. UEI NEN9A34LRHJ5
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $343,526
Award facts
- Contract value 100% obligated
- $343,526.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Parsippany, NJ 07054, USA
Award details come from SAM.gov/FPDS.
About this award
The Medical Supply Chain (Defense) issued a $343,526.40 delivery order to Teva Pharmaceuticals USA, Inc. on July 14, 2026, for Adenovirus Type 4 and Type 7 vaccine supply, with ultimate completion on July 21, 2026.
Place of performance is Parsippany, NJ. The order is firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract SPE2DP26F7456?
SPE2DP26F7456 was awarded to Teva Pharmaceuticals Usa, Inc. by Medical Supply Chain (Troop Support) on July 14, 2026.
How much is contract SPE2DP26F7456 worth?
The government has obligated $343,526 on SPE2DP26F7456.
Is contract SPE2DP26F7456 an order under another contract?
Yes. SPE2DP26F7456 is a delivery order under SPE2DP20D0002, an indefinite delivery contract.
Was contract SPE2DP26F7456 competed?
The extent of competition for SPE2DP26F7456 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award